In the present study, we sought to evaluate the incidence of genetic polymorphisms of some of the key players of angiogenesis, such as VEGFR-2, PDGFR-α and PDGFR-β, and their potential influence in CRC biology. This evidence concerns the gene KDR and colorectal carcinoma.